SlideShare ist ein Scribd-Unternehmen logo
1 von 3
Downloaden Sie, um offline zu lesen
Senology Newsletter                                                                                    Page 1 of 3




                                     Senology.org - Newsletter
                International Senologic and Oncologic  Scientific Community (ISOSC) 

                                          "Connecting specialists worldwide"




                                        Editor-in-Chief: Gian Paolo Andreoletti, MD


                         Subscribe       Unsubscribe            Contact         Back Issues




 Connecting Specialists Worldwide

 Join us on LinkedIn, Twitter, Facebook, ResearchGate, Doctorsbook, Google Groups, YouTube, SlideShare,
 Flickr, and share informations and opinions. Check out Senology.org Newspaper and follow our RSS feeds for
 real-time updates




        de Koning H: "A tribute to Stefano Ciatto (2 June 1949-4 May 2012)", J Med Screen. 2012 Sep 8. [Epub
        ahead of print]

 Literature Selection

        The Cancer Genome Atlas Network : "Comprehensive molecular portraits of human breast tumours",
        Nature. 2012 Sep 23. [Epub ahead of print]
        Pijpe A et al.: "Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2
        mutations: retrospective cohort study (GENE-RAD-RISK)", BMJ. 2012 Sep 6;345:e5660. doi:
        10.1136/bmj.e5660
        Falck AK et al.: "Analysis of and prognostic information from disseminated tumour cells in bone
        marrow in primary breast cancer: a prospective observational study", BMC Cancer. 2012 Sep 11;12
        (1):403. [Epub ahead of print]
        Maaskant-Braat AJ et al.: "Sentinel Node and Recurrent Breast Cancer (SNARB): Results of a
        Nationwide Registration Study", Ann Surg Oncol. 2012 Sep 1. [Epub ahead of print]
        Solà M et al.: "Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer
        Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM
        048/13/2000", Ann Surg Oncol. 2012 Sep 7. [Epub ahead of print]
        Iwata H et al.: "Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients
        receiving goserelin for premenopausal breast cancer", Cancer. 2012 Sep 12. doi: 10.1002/cncr.27818.
        [Epub ahead of print]
        Karasawa K et al.: "Comparison of hypofractionated and conventionally fractionated whole-breast
        irradiation for early breast cancer patients: a single-institute study of 1,098 patients", Breast Cancer.




file://C:Documents and SettingsutenteDesktopNewsl_Oct2012.htm                                      02/10/2012
Senology Newsletter                                                                                       Page 2 of 3




        2012 Sep 12. [Epub ahead of print]
        Cramer H et al.: "Yoga for breast cancer patients and survivors: a systematic review and meta-
        analysis", BMC Cancer. 2012 Sep 18;12(1):412. [Epub ahead of print]

 Comment

        "The European breast screening programmes are preventing large numbers of breast cancer deaths" ,
        Mireille Broeders, Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical
        Centre, Nijmegen, The Netherlands

        "After considering all published data from European studies, the reduction in breast cancer mortality
        associated with mammographic population-based service screening programmes is in the range of 25–31%
        for women invited for screening and 38–48% for women actually screened with sufficient follow-up time. It
        appears that much of the current controversy surrounding the value of mammography screening is due to the
        use of inappropriate methodological approaches that are unable to capture the true effect of mammographic
        screening. Overall, the results of this first comprehensive review of European breast screening services show
        that for every 1,000 women screened every two years from the age of 50 to the age of about 68-69, between
        seven and nine lives would be saved, and four cases would be over-diagnosed. The European breast
        screening programmes are preventing large numbers of breast cancer deaths, and the benefits outweigh the
        harms of screening. The programmes should continue to provide high quality screening services and should
        work towards achieving targets on coverage, uptake and assessment rates. In addition, communication
        methods should be improved in order to raise women’s awareness, and to make information on the pros and
        cons of breast cancer screening more accessible, relevant and comprehensible"
        (Commentary on: Broeders M et al.: "The impact of mammographic screening on breast cancer
        mortality in Europe: a review of observational studies ", J Med Screen 2012 Sep: 19(1): 14-25)


            "Review of breast cancer screening programs in Europe: lives saved by screening outweigh over-
        diagnosed cases by a factor of two to one" - Share your opinion on LinkedIn®

 Calendar of Events

        12th Michelangelo Foundation Seminar: “Moving from adjuvant to neoadjuvant trials for development
        of new therapies in breast cancer: a hopeless heresy or a feasible paradigm shift?”, October 12, 2012
         Milan, Italy
        17th World Congress on Breast Diseases of the Senologic International Society, -SIS, October 10-13,
        2012, Salvador, Bahia, Brazil
        Breast Cancer in Young Women Conference, 8-10 November 8-10, 2012, Dublin, Ireland
        IBUS - International Breast Ultrasound Course, 13 - 15 November 2012, Tel Aviv, Israel
        8th Meet the Professor. Advanced International Breast Cancer Conference (AIBCC), November 15-17,
        2012, Padova , Italy - with the Patronage of Senology.org
        2012 CTRC-AACR San Antonio Breast Cancer Symposium , December 4-8, 2012, San Antonio, TX,
        USA




 Literature Selection

        Stoffels I et al.: "Association between sentinel lymph node excision with or without preoperative
        SPECT/CT and metastatic node detection and disease-free survival in melanoma", JAMA. 2012 Sep
        12;308(10):1007-14
        The Cancer Genome Atlas Research Network: "Comprehensive genomic characterization of
        squamous cell lung cancers", Nature. 2012 Sep 9. doi: 10.1038/nature11404. [Epub ahead of print]
        Moyer VA et al.: "Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation
        Recommendation Statement", Ann Intern Med. 2012 Sep 11 [Epub ahead of print]
        Huang ZM et al.: "Minimally invasive therapies have good survival rate for patients with unresectable
        pancreatic cancer", Chin J Cancer. 2012 Sep 10. doi: 10.5732/cjc.012.10093. [Epub ahead of print]
        Uehara T et al.: "H. pylori Infection Is Associated with DNA Damage of Lgr5-Positive Epithelial Stem
        Cells in the Stomach of Patients with Gastric Cancer", Dig Dis Sci. 2012 Sep 4. [Epub ahead of print]
        Kennedy TJ et al.: "Laparoscopic radiofrequency ablation for the management of colorectal liver
        metastases: 10-year experience", J Surg Oncol. 2012 Sep 20 [Epub ahead of print]
        Lacson JC et al.: "Population-based case-control study of recreational drug use and testis cancer risk
        confirms an association between marijuana use and nonseminoma risk", Cancer. 2012 Sep 10. doi:
        10.1002/cncr.27554. [Epub ahead of print]

 Fragments of History




file://C:Documents and SettingsutenteDesktopNewsl_Oct2012.htm                                         02/10/2012
Senology Newsletter                                                                                         Page 3 of 3




        1914 - Proposal by Theodor Boveri (Bamberg, 1862 - Wurzburg, 1915) that cancer can be triggered by
        chromosomal mutations




 Literature Selection

        Pavone ME et al.: "Aromatase inhibitors for the treatment of endometriosis", Fertil Steril. 2012 Sep 19
        [Epub ahead of print]
        Zeng XT et al.: "Passive Smoking and Cervical Cancer Risk: A Meta-analysis Based on 3,230 Cases
        and 2,982 Controls", Asian Pac J Cancer Prev. 2012;13(6):2687-93




 Senology.org collaborates with TalkAboutHealth.com - "Cancer questions, answers, and support". Follow the
 Expert Q&A Workshops and join the conversation.

 Q&A of the month

        "What is the current status of targeted therapies for ovarian cancer?"

        "Currently the only targeted therapy routinely employed in ovarian cancer is directed at the cancer-
        associated blood vessels. The term, “anti-angiogenesis”, is employed to describe this therapeutic
        concept. The drug, bevacizumab, has been shown to be helpful in some patients when used alone
        (single agent therapy) or employed in combination with certain chemotherapeutic agents. Other
        targeted therapies remain under active clinical investigation (for example, PARP inhibitors), but have
        not at this point in time been approved for routine use by the FDA outside the confines of clinical
        trials"
        (Answer by Maurie Markman, Cancer Treatment Centers of America, USA)




 Stay informed....

 Recent Advances in Clinical Medicine

        Gold R et al.: "Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis ",N
        Engl J Med. 2012 Sep 20;367(12):1098-107




                                                                                                         Unsubscribe



                                                              

                                            www.senology.org




file://C:Documents and SettingsutenteDesktopNewsl_Oct2012.htm                                           02/10/2012

Weitere ähnliche Inhalte

Was ist angesagt?

Senology.org Newsletter - September 9, 2011
Senology.org Newsletter - September 9, 2011Senology.org Newsletter - September 9, 2011
Senology.org Newsletter - September 9, 2011Senology.org
 
Senology.org Newsletter - September 7, 2012
Senology.org Newsletter - September 7, 2012Senology.org Newsletter - September 7, 2012
Senology.org Newsletter - September 7, 2012Senology.org
 
Senology.org Newsletter - November 3, 2011
Senology.org Newsletter - November 3, 2011Senology.org Newsletter - November 3, 2011
Senology.org Newsletter - November 3, 2011Senology.org
 
Senology.org Newsletter - March 2, 2012
Senology.org Newsletter - March 2, 2012Senology.org Newsletter - March 2, 2012
Senology.org Newsletter - March 2, 2012Senology.org
 
Senology Newsletter - December 11, 2013
Senology Newsletter - December 11, 2013Senology Newsletter - December 11, 2013
Senology Newsletter - December 11, 2013Senology.org
 
Senology Newsletter - February 7, 2013
Senology Newsletter - February 7, 2013Senology Newsletter - February 7, 2013
Senology Newsletter - February 7, 2013Senology.org
 
Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...
Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...
Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...Senology.org
 
Senology.org Newsletter - December 6, 2011
Senology.org Newsletter - December 6, 2011Senology.org Newsletter - December 6, 2011
Senology.org Newsletter - December 6, 2011Senology.org
 
Senology.org Newsletter - June 1, 2012
Senology.org Newsletter - June 1, 2012Senology.org Newsletter - June 1, 2012
Senology.org Newsletter - June 1, 2012Senology.org
 
Senology Newsletter - July 3, 2013
Senology Newsletter - July 3, 2013Senology Newsletter - July 3, 2013
Senology Newsletter - July 3, 2013Senology.org
 
Senology Newsletter - May 8, 2012
Senology Newsletter - May 8, 2012Senology Newsletter - May 8, 2012
Senology Newsletter - May 8, 2012Senology.org
 
Senology Newsletter - November 6, 2012
Senology Newsletter - November 6, 2012Senology Newsletter - November 6, 2012
Senology Newsletter - November 6, 2012Senology.org
 
Senology Newsletter - December 11, 2012
Senology Newsletter - December 11, 2012Senology Newsletter - December 11, 2012
Senology Newsletter - December 11, 2012Senology.org
 
Senology Newsletter - January 15, 2013
Senology Newsletter - January 15, 2013Senology Newsletter - January 15, 2013
Senology Newsletter - January 15, 2013Senology.org
 
Senology Newsletter - April 10, 2013
Senology Newsletter - April 10, 2013Senology Newsletter - April 10, 2013
Senology Newsletter - April 10, 2013Senology.org
 
Senology Newsletter - May 2, 2013
Senology Newsletter - May 2, 2013Senology Newsletter - May 2, 2013
Senology Newsletter - May 2, 2013Senology.org
 
Senology Newsletter - November 14, 2013
Senology Newsletter - November 14, 2013Senology Newsletter - November 14, 2013
Senology Newsletter - November 14, 2013Senology.org
 
June 1, 2011 Senology.org Newsletter
June 1, 2011   Senology.org NewsletterJune 1, 2011   Senology.org Newsletter
June 1, 2011 Senology.org NewsletterSenology.org
 
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of SenologySenology.org
 
Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014Senology.org
 

Was ist angesagt? (20)

Senology.org Newsletter - September 9, 2011
Senology.org Newsletter - September 9, 2011Senology.org Newsletter - September 9, 2011
Senology.org Newsletter - September 9, 2011
 
Senology.org Newsletter - September 7, 2012
Senology.org Newsletter - September 7, 2012Senology.org Newsletter - September 7, 2012
Senology.org Newsletter - September 7, 2012
 
Senology.org Newsletter - November 3, 2011
Senology.org Newsletter - November 3, 2011Senology.org Newsletter - November 3, 2011
Senology.org Newsletter - November 3, 2011
 
Senology.org Newsletter - March 2, 2012
Senology.org Newsletter - March 2, 2012Senology.org Newsletter - March 2, 2012
Senology.org Newsletter - March 2, 2012
 
Senology Newsletter - December 11, 2013
Senology Newsletter - December 11, 2013Senology Newsletter - December 11, 2013
Senology Newsletter - December 11, 2013
 
Senology Newsletter - February 7, 2013
Senology Newsletter - February 7, 2013Senology Newsletter - February 7, 2013
Senology Newsletter - February 7, 2013
 
Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...
Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...
Senology.org Newsletter - January 12, 2012 - Latest Advances in Clinical Seno...
 
Senology.org Newsletter - December 6, 2011
Senology.org Newsletter - December 6, 2011Senology.org Newsletter - December 6, 2011
Senology.org Newsletter - December 6, 2011
 
Senology.org Newsletter - June 1, 2012
Senology.org Newsletter - June 1, 2012Senology.org Newsletter - June 1, 2012
Senology.org Newsletter - June 1, 2012
 
Senology Newsletter - July 3, 2013
Senology Newsletter - July 3, 2013Senology Newsletter - July 3, 2013
Senology Newsletter - July 3, 2013
 
Senology Newsletter - May 8, 2012
Senology Newsletter - May 8, 2012Senology Newsletter - May 8, 2012
Senology Newsletter - May 8, 2012
 
Senology Newsletter - November 6, 2012
Senology Newsletter - November 6, 2012Senology Newsletter - November 6, 2012
Senology Newsletter - November 6, 2012
 
Senology Newsletter - December 11, 2012
Senology Newsletter - December 11, 2012Senology Newsletter - December 11, 2012
Senology Newsletter - December 11, 2012
 
Senology Newsletter - January 15, 2013
Senology Newsletter - January 15, 2013Senology Newsletter - January 15, 2013
Senology Newsletter - January 15, 2013
 
Senology Newsletter - April 10, 2013
Senology Newsletter - April 10, 2013Senology Newsletter - April 10, 2013
Senology Newsletter - April 10, 2013
 
Senology Newsletter - May 2, 2013
Senology Newsletter - May 2, 2013Senology Newsletter - May 2, 2013
Senology Newsletter - May 2, 2013
 
Senology Newsletter - November 14, 2013
Senology Newsletter - November 14, 2013Senology Newsletter - November 14, 2013
Senology Newsletter - November 14, 2013
 
June 1, 2011 Senology.org Newsletter
June 1, 2011   Senology.org NewsletterJune 1, 2011   Senology.org Newsletter
June 1, 2011 Senology.org Newsletter
 
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
 
Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014
 

Andere mochten auch

Senology Newsletter - October 9, 2013
Senology Newsletter - October 9, 2013Senology Newsletter - October 9, 2013
Senology Newsletter - October 9, 2013Senology.org
 
Avastin with Xeloda as a first-line treatment for metastatic breast cancer bc_en
Avastin with Xeloda as a first-line treatment for metastatic breast cancer bc_enAvastin with Xeloda as a first-line treatment for metastatic breast cancer bc_en
Avastin with Xeloda as a first-line treatment for metastatic breast cancer bc_enSenology.org
 
Gunna dee blocker presentation
Gunna dee  blocker presentationGunna dee  blocker presentation
Gunna dee blocker presentationJessiea1
 
2010 Middle East State of Supply Chain Management
2010 Middle East State of Supply Chain Management2010 Middle East State of Supply Chain Management
2010 Middle East State of Supply Chain ManagementB2G-Consulting
 
2010 middle east state of supply chain management
2010 middle east state of supply chain management2010 middle east state of supply chain management
2010 middle east state of supply chain managementB2G-Consulting
 
What is copyright
What is copyrightWhat is copyright
What is copyrightMyers23
 
Twitter voicethread
Twitter voicethreadTwitter voicethread
Twitter voicethreadMyers23
 
Assignment Nº 1: History of educational technology
Assignment Nº 1: History of educational technologyAssignment Nº 1: History of educational technology
Assignment Nº 1: History of educational technologygabrielktx
 
Guess Spring Summer 2011
Guess Spring Summer 2011Guess Spring Summer 2011
Guess Spring Summer 2011layoung25
 
Econ11 weaving
Econ11 weavingEcon11 weaving
Econ11 weavingt_ware
 
Positive Phase II results for trastuzumab emtansine (T-DM1)
Positive Phase II results for trastuzumab emtansine (T-DM1)Positive Phase II results for trastuzumab emtansine (T-DM1)
Positive Phase II results for trastuzumab emtansine (T-DM1)Senology.org
 
Blackboard basics 1
Blackboard basics 1Blackboard basics 1
Blackboard basics 1Myers23
 
Senology Newsletter - October 16, 2014
Senology Newsletter - October 16, 2014Senology Newsletter - October 16, 2014
Senology Newsletter - October 16, 2014Senology.org
 
10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...
10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...
10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...Senology.org
 
Senology Newsletter - November 6, 2014
Senology Newsletter - November 6, 2014Senology Newsletter - November 6, 2014
Senology Newsletter - November 6, 2014Senology.org
 
Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...
  Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...  Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...
Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...Senology.org
 

Andere mochten auch (20)

Senology Newsletter - October 9, 2013
Senology Newsletter - October 9, 2013Senology Newsletter - October 9, 2013
Senology Newsletter - October 9, 2013
 
Avastin with Xeloda as a first-line treatment for metastatic breast cancer bc_en
Avastin with Xeloda as a first-line treatment for metastatic breast cancer bc_enAvastin with Xeloda as a first-line treatment for metastatic breast cancer bc_en
Avastin with Xeloda as a first-line treatment for metastatic breast cancer bc_en
 
Gunna dee blocker presentation
Gunna dee  blocker presentationGunna dee  blocker presentation
Gunna dee blocker presentation
 
2010 Middle East State of Supply Chain Management
2010 Middle East State of Supply Chain Management2010 Middle East State of Supply Chain Management
2010 Middle East State of Supply Chain Management
 
2010 middle east state of supply chain management
2010 middle east state of supply chain management2010 middle east state of supply chain management
2010 middle east state of supply chain management
 
What is copyright
What is copyrightWhat is copyright
What is copyright
 
public_hunt
public_huntpublic_hunt
public_hunt
 
Question One
Question OneQuestion One
Question One
 
Twitter voicethread
Twitter voicethreadTwitter voicethread
Twitter voicethread
 
Assignment Nº 1: History of educational technology
Assignment Nº 1: History of educational technologyAssignment Nº 1: History of educational technology
Assignment Nº 1: History of educational technology
 
Question three
Question threeQuestion three
Question three
 
Guess Spring Summer 2011
Guess Spring Summer 2011Guess Spring Summer 2011
Guess Spring Summer 2011
 
Econ11 weaving
Econ11 weavingEcon11 weaving
Econ11 weaving
 
Positive Phase II results for trastuzumab emtansine (T-DM1)
Positive Phase II results for trastuzumab emtansine (T-DM1)Positive Phase II results for trastuzumab emtansine (T-DM1)
Positive Phase II results for trastuzumab emtansine (T-DM1)
 
Blackboard basics 1
Blackboard basics 1Blackboard basics 1
Blackboard basics 1
 
Senology Newsletter - October 16, 2014
Senology Newsletter - October 16, 2014Senology Newsletter - October 16, 2014
Senology Newsletter - October 16, 2014
 
Merit 1
Merit 1Merit 1
Merit 1
 
10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...
10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...
10th Meet the Professor. Advanced International Breast Cancer Conference (AIB...
 
Senology Newsletter - November 6, 2014
Senology Newsletter - November 6, 2014Senology Newsletter - November 6, 2014
Senology Newsletter - November 6, 2014
 
Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...
  Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...  Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...
Senology.org Newsletter - October 4, 2011 - Latest Advances in Clinical Sen...
 

Ähnlich wie Senology Newsletter - October 2, 2012

Senology Newsletter - June 4, 2013
Senology Newsletter - June 4, 2013Senology Newsletter - June 4, 2013
Senology Newsletter - June 4, 2013Senology.org
 
Senology Newsletter - September 10, 2013
Senology Newsletter - September 10, 2013Senology Newsletter - September 10, 2013
Senology Newsletter - September 10, 2013Senology.org
 
Senology Newsletter - March 18, 2015
Senology Newsletter - March 18, 2015Senology Newsletter - March 18, 2015
Senology Newsletter - March 18, 2015Senology.org
 
JOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptxJOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptxAkshata Darandale
 
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...CSCJournals
 
PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...
PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...
PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...IRJET Journal
 
Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015Senology.org
 
USING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASE
USING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASEUSING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASE
USING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASEIJCSEIT Journal
 

Ähnlich wie Senology Newsletter - October 2, 2012 (8)

Senology Newsletter - June 4, 2013
Senology Newsletter - June 4, 2013Senology Newsletter - June 4, 2013
Senology Newsletter - June 4, 2013
 
Senology Newsletter - September 10, 2013
Senology Newsletter - September 10, 2013Senology Newsletter - September 10, 2013
Senology Newsletter - September 10, 2013
 
Senology Newsletter - March 18, 2015
Senology Newsletter - March 18, 2015Senology Newsletter - March 18, 2015
Senology Newsletter - March 18, 2015
 
JOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptxJOURNAL CLUB PRESENTATION.pptx
JOURNAL CLUB PRESENTATION.pptx
 
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (3) Issue...
 
PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...
PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...
PREDICTION OF BREAST CANCER,COMPARATIVE REVIEW OF MACHINE LEARNING TECHNIQUES...
 
Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015
 
USING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASE
USING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASEUSING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASE
USING DATA MINING TECHNIQUES FOR DIAGNOSIS AND PROGNOSIS OF CANCER DISEASE
 

Mehr von Senology.org

Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015Senology.org
 
Senology Newsletter - February 18, 2015
Senology Newsletter - February 18, 2015Senology Newsletter - February 18, 2015
Senology Newsletter - February 18, 2015Senology.org
 
Senology Newsletter - September 9, 2014
Senology Newsletter - September 9, 2014Senology Newsletter - September 9, 2014
Senology Newsletter - September 9, 2014Senology.org
 
Senology Newsletter - July 10, 2014
Senology Newsletter - July 10, 2014Senology Newsletter - July 10, 2014
Senology Newsletter - July 10, 2014Senology.org
 
Senology Newsletter - June 11, 2014
Senology Newsletter - June 11, 2014Senology Newsletter - June 11, 2014
Senology Newsletter - June 11, 2014Senology.org
 
Senology Newsletter - April 16, 2014
Senology Newsletter - April 16, 2014Senology Newsletter - April 16, 2014
Senology Newsletter - April 16, 2014Senology.org
 
Senology Newsletter - March 19, 2014
Senology Newsletter - March 19, 2014Senology Newsletter - March 19, 2014
Senology Newsletter - March 19, 2014Senology.org
 
Senology Newsletter - February 25, 2014
Senology Newsletter - February 25, 2014Senology Newsletter - February 25, 2014
Senology Newsletter - February 25, 2014Senology.org
 

Mehr von Senology.org (8)

Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015
 
Senology Newsletter - February 18, 2015
Senology Newsletter - February 18, 2015Senology Newsletter - February 18, 2015
Senology Newsletter - February 18, 2015
 
Senology Newsletter - September 9, 2014
Senology Newsletter - September 9, 2014Senology Newsletter - September 9, 2014
Senology Newsletter - September 9, 2014
 
Senology Newsletter - July 10, 2014
Senology Newsletter - July 10, 2014Senology Newsletter - July 10, 2014
Senology Newsletter - July 10, 2014
 
Senology Newsletter - June 11, 2014
Senology Newsletter - June 11, 2014Senology Newsletter - June 11, 2014
Senology Newsletter - June 11, 2014
 
Senology Newsletter - April 16, 2014
Senology Newsletter - April 16, 2014Senology Newsletter - April 16, 2014
Senology Newsletter - April 16, 2014
 
Senology Newsletter - March 19, 2014
Senology Newsletter - March 19, 2014Senology Newsletter - March 19, 2014
Senology Newsletter - March 19, 2014
 
Senology Newsletter - February 25, 2014
Senology Newsletter - February 25, 2014Senology Newsletter - February 25, 2014
Senology Newsletter - February 25, 2014
 

Senology Newsletter - October 2, 2012

  • 1. Senology Newsletter Page 1 of 3 Senology.org - Newsletter International Senologic and Oncologic  Scientific Community (ISOSC)  "Connecting specialists worldwide" Editor-in-Chief: Gian Paolo Andreoletti, MD Subscribe Unsubscribe Contact Back Issues Connecting Specialists Worldwide Join us on LinkedIn, Twitter, Facebook, ResearchGate, Doctorsbook, Google Groups, YouTube, SlideShare, Flickr, and share informations and opinions. Check out Senology.org Newspaper and follow our RSS feeds for real-time updates de Koning H: "A tribute to Stefano Ciatto (2 June 1949-4 May 2012)", J Med Screen. 2012 Sep 8. [Epub ahead of print] Literature Selection The Cancer Genome Atlas Network : "Comprehensive molecular portraits of human breast tumours", Nature. 2012 Sep 23. [Epub ahead of print] Pijpe A et al.: "Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)", BMJ. 2012 Sep 6;345:e5660. doi: 10.1136/bmj.e5660 Falck AK et al.: "Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study", BMC Cancer. 2012 Sep 11;12 (1):403. [Epub ahead of print] Maaskant-Braat AJ et al.: "Sentinel Node and Recurrent Breast Cancer (SNARB): Results of a Nationwide Registration Study", Ann Surg Oncol. 2012 Sep 1. [Epub ahead of print] Solà M et al.: "Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048/13/2000", Ann Surg Oncol. 2012 Sep 7. [Epub ahead of print] Iwata H et al.: "Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer", Cancer. 2012 Sep 12. doi: 10.1002/cncr.27818. [Epub ahead of print] Karasawa K et al.: "Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients", Breast Cancer. file://C:Documents and SettingsutenteDesktopNewsl_Oct2012.htm 02/10/2012
  • 2. Senology Newsletter Page 2 of 3 2012 Sep 12. [Epub ahead of print] Cramer H et al.: "Yoga for breast cancer patients and survivors: a systematic review and meta- analysis", BMC Cancer. 2012 Sep 18;12(1):412. [Epub ahead of print] Comment "The European breast screening programmes are preventing large numbers of breast cancer deaths" , Mireille Broeders, Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands "After considering all published data from European studies, the reduction in breast cancer mortality associated with mammographic population-based service screening programmes is in the range of 25–31% for women invited for screening and 38–48% for women actually screened with sufficient follow-up time. It appears that much of the current controversy surrounding the value of mammography screening is due to the use of inappropriate methodological approaches that are unable to capture the true effect of mammographic screening. Overall, the results of this first comprehensive review of European breast screening services show that for every 1,000 women screened every two years from the age of 50 to the age of about 68-69, between seven and nine lives would be saved, and four cases would be over-diagnosed. The European breast screening programmes are preventing large numbers of breast cancer deaths, and the benefits outweigh the harms of screening. The programmes should continue to provide high quality screening services and should work towards achieving targets on coverage, uptake and assessment rates. In addition, communication methods should be improved in order to raise women’s awareness, and to make information on the pros and cons of breast cancer screening more accessible, relevant and comprehensible" (Commentary on: Broeders M et al.: "The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies ", J Med Screen 2012 Sep: 19(1): 14-25) "Review of breast cancer screening programs in Europe: lives saved by screening outweigh over- diagnosed cases by a factor of two to one" - Share your opinion on LinkedIn® Calendar of Events 12th Michelangelo Foundation Seminar: “Moving from adjuvant to neoadjuvant trials for development of new therapies in breast cancer: a hopeless heresy or a feasible paradigm shift?”, October 12, 2012 Milan, Italy 17th World Congress on Breast Diseases of the Senologic International Society, -SIS, October 10-13, 2012, Salvador, Bahia, Brazil Breast Cancer in Young Women Conference, 8-10 November 8-10, 2012, Dublin, Ireland IBUS - International Breast Ultrasound Course, 13 - 15 November 2012, Tel Aviv, Israel 8th Meet the Professor. Advanced International Breast Cancer Conference (AIBCC), November 15-17, 2012, Padova , Italy - with the Patronage of Senology.org 2012 CTRC-AACR San Antonio Breast Cancer Symposium , December 4-8, 2012, San Antonio, TX, USA Literature Selection Stoffels I et al.: "Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma", JAMA. 2012 Sep 12;308(10):1007-14 The Cancer Genome Atlas Research Network: "Comprehensive genomic characterization of squamous cell lung cancers", Nature. 2012 Sep 9. doi: 10.1038/nature11404. [Epub ahead of print] Moyer VA et al.: "Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement", Ann Intern Med. 2012 Sep 11 [Epub ahead of print] Huang ZM et al.: "Minimally invasive therapies have good survival rate for patients with unresectable pancreatic cancer", Chin J Cancer. 2012 Sep 10. doi: 10.5732/cjc.012.10093. [Epub ahead of print] Uehara T et al.: "H. pylori Infection Is Associated with DNA Damage of Lgr5-Positive Epithelial Stem Cells in the Stomach of Patients with Gastric Cancer", Dig Dis Sci. 2012 Sep 4. [Epub ahead of print] Kennedy TJ et al.: "Laparoscopic radiofrequency ablation for the management of colorectal liver metastases: 10-year experience", J Surg Oncol. 2012 Sep 20 [Epub ahead of print] Lacson JC et al.: "Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk", Cancer. 2012 Sep 10. doi: 10.1002/cncr.27554. [Epub ahead of print] Fragments of History file://C:Documents and SettingsutenteDesktopNewsl_Oct2012.htm 02/10/2012
  • 3. Senology Newsletter Page 3 of 3 1914 - Proposal by Theodor Boveri (Bamberg, 1862 - Wurzburg, 1915) that cancer can be triggered by chromosomal mutations Literature Selection Pavone ME et al.: "Aromatase inhibitors for the treatment of endometriosis", Fertil Steril. 2012 Sep 19 [Epub ahead of print] Zeng XT et al.: "Passive Smoking and Cervical Cancer Risk: A Meta-analysis Based on 3,230 Cases and 2,982 Controls", Asian Pac J Cancer Prev. 2012;13(6):2687-93 Senology.org collaborates with TalkAboutHealth.com - "Cancer questions, answers, and support". Follow the Expert Q&A Workshops and join the conversation. Q&A of the month "What is the current status of targeted therapies for ovarian cancer?" "Currently the only targeted therapy routinely employed in ovarian cancer is directed at the cancer- associated blood vessels. The term, “anti-angiogenesis”, is employed to describe this therapeutic concept. The drug, bevacizumab, has been shown to be helpful in some patients when used alone (single agent therapy) or employed in combination with certain chemotherapeutic agents. Other targeted therapies remain under active clinical investigation (for example, PARP inhibitors), but have not at this point in time been approved for routine use by the FDA outside the confines of clinical trials" (Answer by Maurie Markman, Cancer Treatment Centers of America, USA) Stay informed.... Recent Advances in Clinical Medicine Gold R et al.: "Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis ",N Engl J Med. 2012 Sep 20;367(12):1098-107 Unsubscribe       www.senology.org file://C:Documents and SettingsutenteDesktopNewsl_Oct2012.htm 02/10/2012